Archives: Post-Dodds

Supreme Court Orders That Mifepristone Remain Widely Available Pending Appeal in Fifth Circuit

By Amy Fouts and Scott P. Robertson on April 25, 2023 Posted in Post-Dodds

On Friday, April 7, the Northern District of Texas issued a decision blocking the prescribing and dispensing of mifepristone nationwide. The court held that plaintiffs had a substantial likelihood of success on the merits regarding their arguments that the FDA approval of the drug in 2000 was arbitrary and capricious. Accordingly, the court stayed the … Continue Reading

Challenge to the FDA’s Approval of Abortion Medication

By Claire Bass and Amy Fouts on April 17, 2023 Posted in Post-Dodds, Post-Roe

On Friday, April 7, both the Northern District of Texas and the Eastern District of Washington issued decisions impacting the FDA approval of the abortion drug mifepristone. The Texas decision blocks prescribing and dispensing of mifespristone nationwide, while the Washington decision enjoins the FDA from altering the status quo related to mifepristone. The discrepancy is … Continue Reading

Federal Judge Blocks Idaho from Enforcing Abortion Ban in Emergencies

By Amy Fouts, Gregory Tanner and Claire Bass on September 1, 2022 Posted in Post-Dodds

On Aug. 24, the United States District Court for the District of Idaho issued a preliminary injunction blocking the enforcement of Idaho’s new abortion law. The law was set to take effect on Aug. 25, 2022. As previously reported, the U.S. Department of Justice (DOJ) filed suit on Aug. 2 against the state of Idaho, … Continue Reading